David Edmonds (Uehiro Centre, Oxford University) and Nigel Warburton (freelance philosopher/writer) interview top philosophers on a wide range of topics. Two books based on the series have been published by Oxford University Press. We are currently self-funding - donations very welcome via our website http://www.philosophybites.com
…
continue reading
MP3•Episode home
Manage episode 427584630 series 2576774
Content provided by Myles Wakeham and [email protected] (Myles Wakeham). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Myles Wakeham and [email protected] (Myles Wakeham) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
The advancement in technology brings a lot of fear, uncertainty & doubt to us. And recently one such invention appears to be doing this – GLP-1 inhibitors, used for diabetes but discovered to have massive impact on weight. The most common name you will hear is ‘Ozempic’. On this episode, I’m going to delve into this both from a medical & financial angle, and yes…. I’ve been taking Ozempic now for the past 2 months, so I’ll tell you my story with it as well.
308 episodes